JAMA Oncology

SJR Rank #152H-index: 208SJR: 7.399Best quartile: Q1
Journal website: aims, scope and author guidelines
Publisher

American Medical Association

Country

United States

Type

journal

SJR by Edition

20222025036912

Subject Categories

  • Cancer ResearchQ1
  • OncologyQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsEconomic and Financial Impacts of CancerBreast Cancer Treatment StudiesCancer Genomics and DiagnosticsHealth Systems, Economic Evaluations, Quality of LifeProstate Cancer Treatment and ResearchGlobal Cancer Incidence and ScreeningBRCA gene mutations in cancerChildhood Cancer Survivors' Quality of Life

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs03006009001200

Documents per Year

202220250100200300400

Detailed Information

ISSN

2374-2445, 2374-2437

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

9.16

References per Document

15.66

Coverage

2015-2026

Scope

JAMA Oncology is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer

Metrics from SCImago Journal Rank 2025. View on SCImago